<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35533994</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1542-7714</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</Title>
          <ISOAbbreviation>Clin Gastroenterol Hepatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Outcome of Budd-Chiari Syndrome (BCS) patients treated with direct oral anticoagulants (DOACs) - an Austrian multicenter study.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">S1542-3565(22)00449-9</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cgh.2022.04.024</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Direct oral anticoagulants (DOACs) may simplify management of Budd-Chiari Syndrome (BCS). Here we report our experience with off-label use of DOACs for anticoagulation in BCS.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Safety of DOAC vs. vitamin K antagonist (VKA) treatment as well as associated clinical outcomes were retrospectively assessed in 47 BCS patients treated at 6 Austrian centers.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean age at study inclusion was 37.9±14.0 years and mean MELD was 13.1±5.1. Overall, 63.8% (n=30) had decompensated liver disease, and 87.2% (n=41) showed clinical signs of portal hypertension. During a median follow-up of 82.5 (IQR: 43.1-121.8) months, 43 patients (91.5%) received anticoagulation alone or following interventional treatment including 22 patients (46.8%) treated with DOACs (edoxaban: 10, apixaban: 4, rivaroxaban: 3, dabigatran: 3, more than one DOAC sequentially: 2) for a median of 24.4 (5.7-35.1) months. While 72.7% of patients (16/22) were switched from LMWH (n=12) or VKA (n=4) to DOAC after disease stabilization/improvement, 27.3% (6/22) of BCS patients were initially treated with DOAC. 'Complete response' (EASL criteria) was achieved or maintained in 14/22 (63.6%) patients, 'ongoing response' in 2 patients, while disease progressed in 6 patients (including 2 patients with HCC). Four major spontaneous bleedings (18.2%; incidence rate 8.8/100 patient years; n=2 upper-GI-bleeding, n=1 lower-GI-bleeding, n=1 HCC rupture), 7 minor bleedings and one major procedure-related bleeding (4.5%; 2.2/100 patient years) occurred during DOAC therapy. Overall transplant-free survival was 91.6% at 5 years.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">DOACs seem to be effective and safe for long-term anticoagulation in patients with BCS, but confirmation by larger prospective studies is needed.</AbstractText>
          <CopyrightInformation>Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Semmler</LastName>
            <ForeName>Georg</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Liver Study Group, Medical University of Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lindorfer</LastName>
            <ForeName>Alexander</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine IV, Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schaefer</LastName>
            <ForeName>Benedikt</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine I, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bartl</LastName>
            <ForeName>Stefan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine I, Klinikum Wels-Grieskirchen, Wels, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hametner-Schreil</LastName>
            <ForeName>Stephanie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine IV, Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gensluckner</LastName>
            <ForeName>Sophie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine I, Paracelsus Medical University Salzburg, Salzburg, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Balcar</LastName>
            <ForeName>Lorenz</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Liver Study Group, Medical University of Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pomej</LastName>
            <ForeName>Katharina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Liver Study Group, Medical University of Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lampichler</LastName>
            <ForeName>Katharina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trauner</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aigner</LastName>
            <ForeName>Elmar</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine I, Paracelsus Medical University Salzburg, Salzburg, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Datz</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zoller</LastName>
            <ForeName>Heinz</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine I, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hofer</LastName>
            <ForeName>Harald</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine I, Klinikum Wels-Grieskirchen, Wels, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schoefl</LastName>
            <ForeName>Rainer</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine IV, Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mandorfer</LastName>
            <ForeName>Mattias</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Liver Study Group, Medical University of Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reiberger</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Liver Study Group, Medical University of Vienna, Vienna, Austria; Christian Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria. Electronic address: thomas.reiberger@meduniwien.ac.at.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scheiner</LastName>
            <ForeName>Bernhard</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Liver Study Group, Medical University of Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Clin Gastroenterol Hepatol</MedlineTA>
        <NlmUniqueID>101160775</NlmUniqueID>
        <ISSNLinking>1542-3565</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Budd-Chiari Syndrome</Keyword>
        <Keyword MajorTopicYN="N">anticoagulation</Keyword>
        <Keyword MajorTopicYN="N">direct oral anticoagulants</Keyword>
        <Keyword MajorTopicYN="N">vascular liver diseases</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>9</Day>
          <Hour>19</Hour>
          <Minute>28</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35533994</ArticleId>
        <ArticleId IdType="doi">10.1016/j.cgh.2022.04.024</ArticleId>
        <ArticleId IdType="pii">S1542-3565(22)00449-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
